Omifin (clomifene citrate 50 mg tablets)

Brand of clomifene citrate 50 mg tablets registered in Spain (AEMPS registration no. 43880). The only indication authorised in its summary of product characteristics is female infertility due to anovulation or dysovulation and ovarian stimulation; it makes no mention of use in men or of testosterone.

Institutional endorsement by Clínica Evolution

This entry is for information. Your case requires an individual medical assessment.